Gene prioritization through genomic data fusion S Aerts, D Lambrechts, S Maity, P Van Loo, B Coessens, F De Smet, ... Nature biotechnology 24 (5), 537-544, 2006 | 1128 | 2006 |
VEGF: A modifier of the del22q11 (DiGeorge) syndrome? I Stalmans, D Lambrechts, F De Smet, S Jansen, J Wang, S Maity, ... Nature medicine 9 (2), 173-182, 2003 | 344 | 2003 |
A genetic Xenopus laevis tadpole model to study lymphangiogenesis A Ny, M Koch, M Schneider, E Neven, RT Tong, S Maity, C Fischer, ... Nature medicine 11 (9), 998-1004, 2005 | 275 | 2005 |
Multimodal chromatography for purification of biotherapeutics–a review V Halan, S Maity, R Bhambure, AS Rathore Current Protein and Peptide Science 20 (1), 4-13, 2019 | 65 | 2019 |
Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles A Ny, M Koch, W Vandevelde, M Schneider, C Fischer, A Diez-Juan, ... Blood, The Journal of the American Society of Hematology 112 (5), 1740-1749, 2008 | 57 | 2008 |
Charge variant analysis of proposed biosimilar to Trastuzumab P Dakshinamurthy, P Mukunda, BP Kodaganti, BR Shenoy, B Natarajan, ... Biologicals 46, 46-56, 2017 | 55 | 2017 |
A non-innovator version of etanercept for treatment of arthritis S Maity, R Ullanat, S Lahiri, S Shekar, G Sodhan, A Vyas, G Dyaga, ... Biologicals 39 (6), 384-395, 2011 | 21 | 2011 |
Broadly neutralizing antibodies for therapy of viral infections S Srinivasan, M Ghosh, S Maity, R Varadarajan2 Antibody Technology Journal 2016 (6), 1-15, 2015 | 17 | 2015 |
DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof B Prasad, D Unnikrishnan, J Hazarika, KI Rodrigues, M Ghosh, ... US Patent 10,752,674, 2020 | 3 | 2020 |
Novel monoclonal antibody therapeutics for metastatic castration resistant prostate cancer. M Ghosh, KI Rodrigues, S Maity, S Bhattacharjee, Y Manjunath, ... Journal of Clinical Oncology 37 (15_suppl), e14222-e14222, 2019 | 3 | 2019 |
In situ base release for pH maintenance can allow shake flasks to better mimic bioreactor performance for CHO cell culture V Maralingannavar, BR Shenoy, J Hazarika, D Unnikrishnan, A Prabhu, ... Journal of Chemical Technology & Biotechnology 93 (10), 2842-2850, 2018 | 2 | 2018 |
Microbial expression of Exendin-4 analog and its efficacy in mice model BP Kodaganti, P Mukunda, P Dakshinamurthy, Y Manjunath, BR Shenoy, ... Biologicals 48, 82-91, 2017 | 2 | 2017 |
An expression vector carrying scaffold/matrix attachment region (s) VM Patell, R Ullanat, S Maity, S Joshi | 2 | 2011 |
Antibodies that bind to c-type lectin domain family 2 member d (clec2d) KI Rodrigues, M Ghosh, S Maity, YMB Muniraju, S Murugesan, ... US Patent App. 18/314,117, 2024 | | 2024 |
Antibodies that bind to c-type lectin domain family 2 member d (CLEC2D) KI Rodrigues, M Ghosh, S Maity, YMB Muniraju, S Murugesan, ... US Patent 11,827,710, 2023 | | 2023 |
DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof B Prasad, D Unnikrishnan, J Hazarika, KI Rodrigues, M Ghosh, ... US Patent 11,548,937, 2023 | | 2023 |
Vectors for cloning and expression of proteins, methods and applications thereof S Chatterjee, KI Rodrigues, M Ghosh, S Maity, D Unnikrishnan, ... US Patent 11,549,119, 2023 | | 2023 |
Method of generating an antibody naïve library, said library and application (s) thereof S Chatterjee, KI Rodrigues, M Ghosh, S Maity, D Unnikrishnan, ... US Patent 11,384,354, 2022 | | 2022 |
Afucosylated protein, cell expressing said protein and associated methods S Chatterjee, KI Rodrigues, M Ghosh, S Maity, D Unnikrishnan, ... US Patent 11,267,899, 2022 | | 2022 |
Method of generating a synthetic antibody library, said library and application (s) thereof S Chatterjee, KI RODRIGUES, M Ghosh, S Maity, D Unnikrishnan, ... US Patent 11,230,706, 2022 | | 2022 |